• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拯救脓毒症运动:成年患者的液体复苏和血管活性药物治疗研究重点

The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients.

作者信息

Lat Ishaq, Coopersmith Craig M, De Backer Daniel, Coopersmith Craig M

机构信息

Department of Pharmacy, Shirley Ryan Abilitylab, Chicago, IL, USA.

Department of Surgery and Emory Critical Care Center, Emory University, Atlanta, GA, USA.

出版信息

Intensive Care Med Exp. 2021 Mar 1;9(1):10. doi: 10.1186/s40635-021-00369-9.

DOI:10.1186/s40635-021-00369-9
PMID:33644843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7917035/
Abstract

OBJECTIVE

To expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.

DATA SOURCES

Original paper and literature search.

STUDY SELECTION

Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.

DATA EXTRACTION

None.

DATA SYNTHESIS

None.

CONCLUSION

In the second of a series of manuscripts subsequent to the original paper, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.

摘要

目的

扩展由危重病医学会和欧洲重症监护医学会指定的一组专家确定的液体复苏和血管活性药物治疗研究重点的优先事项。

数据来源

原始论文和文献检索。

研究选择

原始工作组中几位在液体复苏和血管活性药物治疗领域具有特定专业知识的成员。

数据提取

无。

数据综合

无。

结论

在原始论文之后的一系列手稿中的第二篇,该领域的专家成员阐述了与液体复苏和血管活性药物治疗相关的三个已确定的优先事项。本分析总结了已知内容以及确定的正在进行和未来的研究。

相似文献

1
The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients.拯救脓毒症运动:成年患者的液体复苏和血管活性药物治疗研究重点
Intensive Care Med Exp. 2021 Mar 1;9(1):10. doi: 10.1186/s40635-021-00369-9.
2
The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients.拯救脓毒症运动:成年患者液体复苏和血管活性药物治疗研究重点
Crit Care Med. 2021 Apr 1;49(4):623-635. doi: 10.1097/CCM.0000000000004864.
3
The surviving sepsis campaign: basic/translational science research priorities.拯救脓毒症运动:基础/转化科学研究重点
Intensive Care Med Exp. 2020 Jul 17;8(1):31. doi: 10.1186/s40635-020-00312-4.
4
The Surviving Sepsis Campaign: Basic/Translational Science Research Priorities.拯救脓毒症运动:基础/转化科学研究重点。
Crit Care Med. 2020 Aug;48(8):1217-1232. doi: 10.1097/CCM.0000000000004408.
5
Surviving Sepsis Campaign Research Priorities 2023.拯救脓毒症运动 2023 年研究重点。
Crit Care Med. 2024 Feb 1;52(2):268-296. doi: 10.1097/CCM.0000000000006135. Epub 2024 Jan 19.
6
Surviving sepsis campaign: research priorities for sepsis and septic shock.拯救脓毒症运动:脓毒症和脓毒性休克的研究重点。
Intensive Care Med. 2018 Sep;44(9):1400-1426. doi: 10.1007/s00134-018-5175-z. Epub 2018 Jul 3.
7
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.拯救脓毒症运动:严重脓毒症和脓毒性休克治疗国际指南:2008年版
Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41.
8
Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.拯救脓毒症运动:脓毒症和脓毒性休克的研究重点。
Crit Care Med. 2018 Aug;46(8):1334-1356. doi: 10.1097/CCM.0000000000003225.
9
An international survey of adherence to Surviving Sepsis Campaign Guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock.一项关于在脓毒性休克初始治疗中遵循 2016 年《拯救脓毒症运动指南》进行液体复苏和血管加压药治疗的国际调查。
J Crit Care. 2022 Apr;68:144-154. doi: 10.1016/j.jcrc.2021.11.016. Epub 2021 Dec 9.
10
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.

引用本文的文献

1
The role of artificial intelligence in sepsis in the Emergency Department: a narrative review.人工智能在急诊科脓毒症中的作用:一项叙述性综述。
Ann Transl Med. 2025 Feb 28;13(1):4. doi: 10.21037/atm-24-150. Epub 2025 Feb 25.
2
Modified Quick Change Method for Norepinephrine Syringe Exchange in Critically Ill Patients: A Quasi-randomized, Non-inferiority Trial.危重症患者去甲肾上腺素注射器更换的改良快速更换法:一项半随机、非劣效性试验。
Cureus. 2024 Dec 4;16(12):e75082. doi: 10.7759/cureus.75082. eCollection 2024 Dec.
3
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb in Patients with Hyperinflammation: A Prospective Study.细胞因子吸附器CytoSorb对炎症反应亢进患者促炎和抗炎调节因子的体外清除:一项前瞻性研究
Infect Dis Ther. 2024 Sep;13(9):2089-2101. doi: 10.1007/s40121-024-01028-8. Epub 2024 Aug 18.
4
Identifying a list of healthcare 'never events' to effect system change: a systematic review and narrative synthesis.确定一组医疗保健“永不发生”事件,以推动系统变革:系统评价和叙述性综合。
BMJ Open Qual. 2023 Jun;12(2). doi: 10.1136/bmjoq-2023-002264.
5
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department.2023年成人脓毒症和感染性休克最新进展:急诊科管理
J Clin Med. 2023 Apr 28;12(9):3188. doi: 10.3390/jcm12093188.
6
Clinical Decision-Making in Practice with New Critical Care Ultrasound Methods for Assessing Respiratory Function and Haemodynamics in Critically Ill Patients.危重症患者呼吸功能和血流动力学评估新重症监护超声方法在临床实践中的决策制定
Clin Pract. 2022 Nov 25;12(6):986-1000. doi: 10.3390/clinpract12060102.
7
Feasibility study using longitudinal bioelectrical impedance analysis to evaluate body water status during fluid resuscitation in a swine sepsis model.在猪脓毒症模型中使用纵向生物电阻抗分析评估液体复苏期间身体水合状态的可行性研究。
Intensive Care Med Exp. 2022 Dec 6;10(1):51. doi: 10.1186/s40635-022-00480-5.
8
An interpretable RL framework for pre-deployment modeling in ICU hypotension management.一种用于重症监护病房低血压管理预部署建模的可解释强化学习框架。
NPJ Digit Med. 2022 Nov 18;5(1):173. doi: 10.1038/s41746-022-00708-4.
9
Pathophysiology of fluid administration in critically ill patients.危重症患者液体输注的病理生理学
Intensive Care Med Exp. 2022 Nov 4;10(1):46. doi: 10.1186/s40635-022-00473-4.
10
State-of-the-art surgery for sigmoid diverticulitis.乙状结肠憩室炎的最新手术治疗方法。
Langenbecks Arch Surg. 2022 Feb;407(1):1-14. doi: 10.1007/s00423-021-02288-5. Epub 2021 Sep 23.

本文引用的文献

1
Resuscitation Guided by Volume Responsiveness Does Not Reduce Mortality in Sepsis: A Meta-Analysis.容量反应性指导下的复苏不能降低脓毒症死亡率:一项荟萃分析。
Crit Care Explor. 2019 May 23;1(5):e0015. doi: 10.1097/CCE.0000000000000015. eCollection 2019 May.
2
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.降低血管升压药暴露对老年血管舒张性低血压危重症患者90天死亡率的影响:一项随机临床试验
JAMA. 2020 Mar 10;323(10):938-949. doi: 10.1001/jama.2020.0930.
3
Lower vs Higher Fluid Volumes During Initial Management of Sepsis: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.低容量与高容量液体复苏治疗脓毒症的初始阶段:系统评价、Meta 分析与序贯试验分析。
Chest. 2020 Jun;157(6):1478-1496. doi: 10.1016/j.chest.2019.11.050. Epub 2020 Jan 23.
4
Association Between Volume of Fluid Resuscitation and Intubation in High-Risk Patients With Sepsis, Heart Failure, End-Stage Renal Disease, and Cirrhosis.容量复苏与高危患者脓毒症、心力衰竭、终末期肾病和肝硬化患者插管的关系。
Chest. 2020 Feb;157(2):286-292. doi: 10.1016/j.chest.2019.09.029. Epub 2019 Oct 14.
5
154 compared to 54 mmol per liter of sodium in intravenous maintenance fluid therapy for adult patients undergoing major thoracic surgery (TOPMAST): a single-center randomized controlled double-blind trial.与成人胸部大手术(TOPMAST)患者静脉维持液治疗中 54mmol/L 的钠相比,154mmol/L 的钠:一项单中心随机对照双盲试验。
Intensive Care Med. 2019 Oct;45(10):1422-1432. doi: 10.1007/s00134-019-05772-1. Epub 2019 Oct 1.
6
Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.以外周灌注状态为目标的复苏策略与脓毒性休克患者血清乳酸水平的影响。ANDROMEDA-SHOCK 试验的贝叶斯再分析。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):423-429. doi: 10.1164/rccm.201905-0968OC.
7
Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.脓毒症患者中平衡晶体液与生理盐水的比较: SMART 临床试验的二次分析。
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1487-1495. doi: 10.1164/rccm.201903-0557OC.
8
Balanced Crystalloids Versus Saline in Critically Ill Adults: A Systematic Review and Meta-analysis.平衡晶体液与生理盐水在危重症成人中的比较:系统评价和荟萃分析。
Ann Pharmacother. 2020 Jan;54(1):5-13. doi: 10.1177/1060028019866420. Epub 2019 Jul 31.
9
Lactated Ringer's Versus 4% Albumin on Lactated Ringer's in Early Sepsis Therapy in Cancer Patients: A Pilot Single-Center Randomized Trial.乳酸林格氏液与白蛋白联合乳酸林格氏液在癌症患者早期脓毒症治疗中的比较:一项单中心随机试验的初步研究。
Crit Care Med. 2019 Oct;47(10):e798-e805. doi: 10.1097/CCM.0000000000003900.
10
Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children.用于重症成人和儿童复苏的缓冲溶液与0.9%生理盐水的比较。
Cochrane Database Syst Rev. 2019 Jul 19;7(7):CD012247. doi: 10.1002/14651858.CD012247.pub2.